Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-030729
Filing Date
2013-05-24
Accepted
2013-05-24 16:45:05
Documents
1
Period of Report
2013-05-22

Document Format Files

Seq Description Document Type Size
1 GONELLA 05/22/2013 rrd381053.html 4  
1 GONELLA 05/22/2013 rrd381053.xml 4 3295
  Complete submission text file 0001181431-13-030729.txt   4982
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O ANTARES PHARMA INC 707 EAGLEVIEW BLVD SUITE 414 EXTON PA 19341
Business Address
GONELLA JACQUES (Reporting) CIK: 0001189296 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 13872641